Please login to the form below

I have forgotten my password

J&J’s Imbruvica wins new cancer indication

FDA backs drug’s use in chronic lymphocytic leukaemia patients with genetic mutation

Novartis' glaucoma combo cleared in Europe

Simbrinza approved to treat eye condition

Reckitt Benckiser confirms pharma spin-off plans

Will separate prescription and consumer health businesses

Amgen launches bowel cancer web portal in Spain

Aims to help healthcare professionals understand about personalised medicine

AZ signs two companion diagnostic deals

Will help identify patients suitable for treatment with lung cancer drugs

Plegridy approval underlines Biogen Idec's dominance in MS

And Tecfidera boosts pharma company’s second quarter financial results

Two blood cancer drugs among CHMP recommendations

Five new drugs, including Janssen’s Imbruvica and Gilead’s Zydelig, backed for use in Europe

Puppet crooner promotes World Hepatitis Day

The World Hepatitis Alliance uses Richard Cheese song to raise awareness

Nexavar fails late-stage breast cancer trial

Bayer’s oncology drug unable to improve progression free survival in new indication

This month in 1989: the creation of Bristol-Myers Squibb

The emergence of a company with a new focus on healthcare and research

Managing pharma's uncertainty

Futures we can’t predict need a strategy we can’t plan
Channel strategy and orphan drugs

A plan for guiding decisions about a product's distribution channel is particularly relevant for orphan drugs, rare diseases or specialty medicines

More features

GSK seeks approval for first malaria vaccine

Submits marketing application to European Medicines Agency
FDA approves pain drug that has reduced risk of abuse

Purdue’s Targiniq ER developed to deter snorting and injection
Neupogen will be first biologic on FDA biosimilars pathway

US regulator will review Novartis’ version of Amgen's Neupogen (filgrastim) over the coming months
Turkey aims to become ‘global player’ in biopharma

Government pledges to boost country’s support for medicines access and R&D
FDA approves Gilead drug in three blood cancers

Zydelig recommended for use in chronic lymphocytic leukaemia and two forms of lymphoma
BMJ accuses Boehringer of withholding Pradaxa data

Claims current FDA recommendation for anticoagulant may be flawed
Community pharmacies central to diabetes fight in UK

Risk assessments can help identify people at risk of developing condition

More news

Latest appointments

Peix appoints online marketing manager

Marie Kruger joins German agency
Cipla names Adil Zainulbhai to board

He has experience at consulting firm McKinsey & Company
Milestone names chief medical officer

Francis Plat bring experience from Merck, Daiichi-Sankyo, Novartis and BMS to the role
Genentech’s Sunil Agarwal joins rare disease firm

He will serve as chief medical officer at Ultragenyx
Philips names head of healthcare for South Asia

Sameer Garde takes role at tech company

More appointments

Featured jobs

Joint Managing Director, Medical Communications, London, £100-120...: £100-120K

Global CEO, Healthcare PR, London or US, Industry leading package: Industry leading package

Account Executive: Competitive + excellent benefits
Fleishman-Hillard UK Ltd

Medical Writer, Consumer Health/ Medical Communications, London: Highly Competitive package

Business Unit Director, Medical Communications, London, Circa £10...: Circa £100-120K

Senior Account Executive, Consumer Health/ Medical Communications, Lon...: Highly Competitive package

Senior Client Engagement Manager – Health Engagement and Communication...: Excellent salary, pension and company bonus

Digital Planner – Digital Agency – London: Competitive

Medical Writer/ Consultant, Market Access & HEOR, London, Very com...: Very competitive package

Business Development Manager - Healthcare Digital Media: Competitive salary and high commission

Associate Director, Client Engagement - Communications - Berkshire: Excellent salary + benefits including pension and company bonus

Medical Communications Business Leader, London, £100-120K: £100-120K

Head of Consumer Health - Healthcare PR: Competitive

Head of Client Services, London, Diverse communications agency, circa ...: Circa £80K

Account Manager, Consumer Health/ Medical Communications, London: Highly Competitive package

Business Unit Director, Medical Communications, London, Circa 75K: Circa £80K

Senior Account Manager, Healthcare PR, London, Excellent Package: Excellent Package

Senior Account Director/ Account Director, Healthcare Brand Communicat...: Highly Competitive package

Senior Account Manager, Consumer Health/ Digital focus, Excellent pack...: Excellent Package

Director, Healthcare PR, London, Excellent Package: Excellent Package

Account Director/ Senior Account Director, OTC - TV, Digital, PR, Lond...: Highly Competitive package

Group Account Director, Healthcare Advertising, London £80-90K: £80-90K

Head of Copy, Healthcare Advertising/ Multichannel Agency, SE England,...: Highly Competitive package

Scientific Director, Medical Communications, London, Circa 80K: Circa £80K

Subscribe to our email news alerts

PMHub

Add my company

Magnetic

If you want an agency with hands-on experience of core campaign development and European implementation.If you want an agency whose...

Latest intelligence

M3 improves personalisation of pharma engagement with doctors: Launches new messaging service on Doctors.net.uk...
Digital Futures 2014 slide deck: Full slides, including survey data, from PMLiVE's digital pharma marketing online event...
The Chinese diabetes challenge: Marketing, communications and commercial relationships in China are full of pitfalls for the unwary, but not without great potential ...